Novo Nordisk is under pressure to cut US prices of its weight loss drug, as demand soars.
Source link
Novo Nordisk is under pressure to cut US prices of its weight loss drug, as demand soars.
Source link
Petr Bystron is accused of received money from Russia in return for influence, which he denies. Source link
Read more